Menu Search

Company Announcements

Belluscura PLC, Tekcapital PLC

Holding(s) in Company

Source: RNS
RNS Number : 8080E
Belluscura PLC
31 October 2022
 

31 October 2022

 

Belluscura PLC

("Belluscura" or the "Company")

 

Notification of Major Holding

 

Belluscura PLC (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that the Company has received notification that Tekcapital Plc has reduced its holding from 13.932% to 12.3062% of the total voting rights of the Company.  TekCapital Plc and now holds 15,138,767 Belluscura ordinary shares of 1p each.

 

The share sale was undertaken on 28 October 2022 by Dowgate Capital who have placed the shares with new and existing shareholders. Tekcapital Plc has undertaken that they will not sell any further shares in Belluscura for a minimum period of six months following the share placing, unless both the Company and Dowgate Capital consent to any such share disposals.

 

 

 

Belluscura plc

www.belluscura.com

Robert Rauker, Chief Executive Officer

via MHP Communications

Anthony Dyer, Chief Financial Officer


 


SPARK Advisory Partners Ltd
(Nominated Adviser)

Tel: +44 (0)20 3368 3550

Neil Baldwin


 


Dowgate Capital Ltd
(Broker)

Tel: +44 (0)20 3903 7715

James Serjeant / Nicholas Chambers


 


MHP Communications
 (Media & Investor Relations)

Tel: +44 (0)20 3128 8100
 or belluscura@mhpc.com

Katie Hunt / Pete Lambie / Matthew Taylor 





 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLDFLFXLBLZFBL